Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats bronchoconstriction. Sold as Foradil, Foradil Certihaler, Perforomist. Every FDA application for this active ingredient: 4 branded and 10 generic.
As of Nov 15, 2026, FDA lists 14 applications for Formoterol Fumarate (sold as Foradil, Foradil Certihaler, Perforomist), first approved Feb 16, 2001, with 1 new use approved and 0 published complete response letters.
First approved: Feb 16, 2001
Applications: 14
New uses approved: 1
Complete response letters: 0
Medicare spending, 2025: $24.6M
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Formoterol Fumarate
Part B
$17.8M
-42%
24,849
Formoterol Fumarate
Part D
$6.5M
-4%
3,687
Perforomist
Part D
$204K
-56%
70
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
FORMOTEROL 20 MCG/2 ML NEB VL: $1.24 per MLGeneric · -64% in a year
PERFOROMIST 20 MCG/2 ML SOLN: $10.08 per MLBrand · +3% in a year
Oxis, new approvalDrugs with a new indication and a new dosage for the alleviation of various symptoms due to airway obstructive impairment in chronic obstructive pulmonary… · AstraZeneca K.K. · Jun 29, 2012
Clinical Trials
44 open or ongoing studies name this ingredient as an intervention, including as a comparator; newest first. See all
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Novartis
Alembic
Lupin